Cargando…

Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together

Histone deacetylase inhibitors (HDIs) are promising anti-cancer agents that inhibit proliferation of many types of cancer cells including breast carcinoma (BC) cells. In the present study, we investigated the influence of the Notch1 activity level on the pharmacological interaction between cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wawruszak, Anna, Luszczki, Jarogniew, Halasa, Marta, Okon, Estera, Landor, Sebastian, Sahlgren, Cecilia, Rivero-Muller, Adolfo, Stepulak, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153599/ https://www.ncbi.nlm.nih.gov/pubmed/34068438 http://dx.doi.org/10.3390/ijms22105184

Ejemplares similares

Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin—An Isobolographic Analysis in Breast Cancer In Vitro Models
por: Hałasa, Marta, et al.
Publicado: (2021)

Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis
por: Wawruszak, Anna, et al.
Publicado: (2019)

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
por: Wawruszak, Anna, et al.
Publicado: (2019)

Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin
por: Okon, Estera, et al.
Publicado: (2020)

Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines – An Isobolographic Analysis
por: Wawruszak, Anna, et al.
Publicado: (2015)

Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
por: Wawruszak, Anna, et al.
Publicado: (2022)

Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
por: Wawruszak, Anna, et al.
Publicado: (2022)

Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells
por: Wawruszak, Anna, et al.
Publicado: (2022)

Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
por: Wawruszak, Anna, et al.
Publicado: (2019)

Valproic Acid and Breast Cancer: State of the Art in 2021
por: Wawruszak, Anna, et al.
Publicado: (2021)

Advances in Chemistry and Bioactivity of Magnoflorine and Magnoflorine-Containing Extracts
por: Okon, Estera, et al.
Publicado: (2020)

Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells
por: Grabarska, Aneta, et al.
Publicado: (2017)

Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells
por: Okon, Estera, et al.
Publicado: (2020)

Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021)

Decoding the PTM-switchboard of Notch
por: Antfolk, Daniel, et al.
Publicado: (2019)

Advancements in Zebrafish Models for Breast Cancer Research: Unveiling Biomarkers, Targeted Therapies, and Personalized Medicine
por: Wawruszak, Anna, et al.
Publicado: (2023)

Emodin-8-O-Glucoside—Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors
por: Okon, Estera, et al.
Publicado: (2023)

MicroRNAs-Role in Lung Cancer
por: Guz, Małgorzata, et al.
Publicado: (2014)

Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2021)

Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
por: Marzęda, Paweł, et al.
Publicado: (2022)

Comparison of the Anticancer Effects of Arvanil and Olvanil When Combined with Cisplatin and Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
por: Marzęda, Paweł, et al.
Publicado: (2022)

Optogenetic control of NOTCH1 signaling
por: Kałafut, Joanna, et al.
Publicado: (2022)

Deacetylation of Transcription Factors in Carcinogenesis
por: Halasa, Marta, et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone deacetylase mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity
por: Ranganathan, Punithavathi, et al.
Publicado: (2016)

Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines—An Isobolographic Analysis
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2022)

H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy
por: Hałasa, Marta, et al.
Publicado: (2019)

Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021)

Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer
por: Okon, Estera, et al.
Publicado: (2023)

Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells
por: Stockhausen, M-T, et al.
Publicado: (2005)

Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
por: Mei, Qinglang, et al.
Publicado: (2023)

PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion
por: Landor, Sebastian K.J., et al.
Publicado: (2021)

Isobolographic Analysis Demonstrates the Additive and Synergistic Effects of Gemcitabine Combined with Fucoidan in Uterine Sarcomas and Carcinosarcoma Cells
por: Bobiński, Marcin, et al.
Publicado: (2019)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

The histone deacetylase HDAC1 positively regulates Notch signaling during Drosophila wing development
por: Wang, Zehua, et al.
Publicado: (2018)

Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells
por: Li, Dengwen, et al.
Publicado: (2014)

Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis cretica, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin
por: Grabarska, Aneta, et al.
Publicado: (2021)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells
por: Gueugnon, Fabien, et al.
Publicado: (2014)

Histone Deacetylase Activity Selectively Regulates Notch-Mediated Smooth Muscle Differentiation in Human Vascular Cells
por: Tang, Yuefeng, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3san2hu6akap0gqhqn6gq8tjd9